Results
74,050 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 28 |  Richard BlumenthalDSpouse | ZdP Investments Fund I, LP Company: ZdP Investments Fund I, LP (Palo Alto, CA) Description: Private Equity Fund Purchase | BUY |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 28 | Richard BlumenthalDSpouse | ZdP Investments Fund I, LP Company: ZdP Investments Fund I, LP (Palo Alto, CA) Description: Private Equity Fund Purchase | BUY |
| $1,001 – $15K |
| Oct 26, 2026 traded Sep 23, 2026 |
| 28 | Opaleye Management Inc.10% Owner |  ACOGAlpha Cognition Inc.Open-market purchase | BUY | $123K 15.0K sh | Oct 26, 2026 traded Oct 23, 2026 |
| 26 | Lyons EmerChief Accounting Officer |  ICLRICON PLCOpen-market sale | SELL | $7,839 43 sh | Oct 26, 2026 traded Oct 23, 2026 |
| 26 | Jordan Rhett D.EVP & CHIEF CREDIT OFFICER |  SMBKSMARTFINANCIAL INC.Open-market sale | SELL | $9,960 200 sh | Oct 26, 2026 traded Oct 26, 2026 |
| 26 | Lyons EmerChief Accounting Officer | ICLRICON PLC Open-market sale | SELL | $7,583 42 sh | Oct 26, 2026 traded Oct 23, 2026 |
| 26 | Lyons EmerChief Accounting Officer | ICLRICON PLC Open-market sale | SELL | $9,538 52 sh | Oct 26, 2026 traded Oct 23, 2026 |
| 25 | Leslie Ericka TChief Administrative Officer |  GSGOLDMAN SACHS GROUP INCOpen-market sale | SELL | $163K 183 sh | Oct 26, 2026 traded Oct 22, 2026 |
| 25 | Opaleye Management Inc.10% Owner |  GRCEGrace Therapeutics, Inc.Open-market purchase | BUY | $41K 21.4K sh | Oct 26, 2026 traded Oct 22, 2026 |
| 25 | Leslie Ericka TChief Administrative Officer | GSGOLDMAN SACHS GROUP INC Open-market sale | SELL | $60K 67 sh | Oct 26, 2026 traded Oct 22, 2026 |
| 25 | Eagan John BuckleyGeneral Counsel |  BBTBeacon Financial CorpOpen-market sale | SELL | $20K 641 sh | Oct 26, 2026 traded Oct 26, 2026 |
| 25 | Spence John YogiVice President |  XFLTXAI Floating Rate & Alternative Income TrustOpen-market purchase | BUY | $17K 1,000 sh | Oct 26, 2026 traded Oct 23, 2026 |
| 24 | Touami SofiaChief Business Officer |  LYCALycia Therapeutics, Inc.Grant or award | A | — 68.8K sh | Oct 26, 2026 traded Aug 11, 2026 |
| 24 | Fischer LaurentDirector | LYCALycia Therapeutics, Inc. Grant or award | A | — 13.3K sh | Oct 26, 2026 traded Aug 11, 2026 |
| 24 | Tsang Chi KeungDirector, Chief Executive Officer |  BMNRBITMINE IMMERSION TECHNOLOGIES, INC.Option exercise | M | — 142 sh | Oct 26, 2026 traded Jul 23, 2026 |
| 24 | Bachrodt AmyChief Financial Officer, 10% Owner | LYCALycia Therapeutics, Inc. Grant or award | A | — 399.7K sh | Oct 26, 2026 traded Aug 11, 2026 |
| 24 | Trombley Aetna WunDirector, President and CEO, 10% Owner | LYCALycia Therapeutics, Inc. Grant or award | A | — 443.6K sh | Oct 26, 2026 traded Aug 11, 2026 |
| 24 | Staben StevenChief Scientific Officer, 10% Owner | LYCALycia Therapeutics, Inc. Grant or award | A | — 110.9K sh | Oct 26, 2026 traded Aug 11, 2026 |
| 24 | Tsang Chi KeungDirector, Chief Executive Officer | BMNRBITMINE IMMERSION TECHNOLOGIES, INC. Grant or award | A | — 30.2K sh | Oct 26, 2026 traded Apr 2, 2026 |
| 24 | Tsang Chi KeungDirector, Chief Executive Officer | BMNRBITMINE IMMERSION TECHNOLOGIES, INC. Grant or award | A | — 4,186 sh | Oct 26, 2026 traded Apr 7, 2026 |
| 24 | Reuter EmilyCHIEF FINANCIAL OFFICER |  CARTMaplebear Inc.Open-market sale · 10b5-1 plan | SELL | $2.75M 50.0K sh | Oct 26, 2026 traded Oct 23, 2026 |
| 24 | Henderson JaneDirector | LYCALycia Therapeutics, Inc. Grant or award | A | — 57.7K sh | Oct 26, 2026 traded Aug 11, 2026 |
| 24 | Richard BlumenthalDSpouse |  STLNStarling Oncology, Inc.Sale (Partial) | SELL | $15K – $50K | Oct 26, 2026 traded Sep 22, 2026 |
| 24 | Richard BlumenthalDSpouse | STLNStarling Oncology, Inc. Sale (Partial) | SELL | $1,001 – $15K | Oct 26, 2026 traded Sep 18, 2026 |
| 24 | Richard BlumenthalDSpouse | STLNStarling Oncology, Inc. Sale (Partial) | SELL | $15K – $50K | Oct 26, 2026 traded Sep 22, 2026 |
| 24 | Richard BlumenthalDSpouse | MH Built to Last LLC Company: MH Built to Last LLC (New York, NY) Description: Partnership Purchase | BUY | $1,001 – $15K | Oct 26, 2026 traded Oct 7, 2026 |
| 24 | Richard BlumenthalDSpouse | MH Built to Last LLC Company: MH Built to Last LLC (New York, NY) Description: Partnership Purchase | BUY | $1,001 – $15K | Oct 26, 2026 traded Oct 7, 2026 |
| 24 | Richard BlumenthalDSpouse | MH Built to Last LLC Company: MH Built to Last LLC (New York, NY) Description: Partnership Purchase | BUY | $1,001 – $15K | Oct 26, 2026 traded Oct 7, 2026 |
| 24 | Richard BlumenthalDSpouse | MH Built to Last LLC Company: MH Built to Last LLC (New York, NY) Description: Partnership Purchase | BUY | $1,001 – $15K | Oct 26, 2026 traded Oct 7, 2026 |
| 24 | Richard BlumenthalDSpouse | STLNStarling Oncology, Inc. Sale (Partial) | SELL | $15K – $50K | Oct 26, 2026 traded Sep 22, 2026 |
| 24 | Richard BlumenthalDSpouse | STLNStarling Oncology, Inc. Sale (Partial) | SELL | $1,001 – $15K | Oct 26, 2026 traded Sep 18, 2026 |
| 24 | Wilson Kenneth L.GEVP Chief Wealth Officer |  CFRCULLEN/FROST BANKERS, INC.Tax withholding | F | $193K 1,230 sh | Oct 26, 2026 traded Oct 24, 2026 |
| 24 | Lee Chin HyokChief Medical Officer, 10% Owner | LYCALycia Therapeutics, Inc. Grant or award | A | — 73.2K sh | Oct 26, 2026 traded Aug 11, 2026 |
| 24 | Tsang Chi KeungDirector, Chief Executive Officer | BMNRBITMINE IMMERSION TECHNOLOGIES, INC. Grant or award | A | — 15.1K sh | Oct 26, 2026 traded Apr 2, 2026 |
| 23 | Perriman Damien AlanChief Commercial Officer |  EXOZEXOZYMES INC.Option exercise | M | — 3,922 sh | Oct 26, 2026 traded Oct 9, 2026 |
| 23 | Perriman Damien AlanChief Commercial Officer | EXOZEXOZYMES INC. Option exercise | M | — 3,922 sh | Oct 26, 2026 traded Oct 9, 2026 |
| 23 | Tsang Chi KeungDirector, Chief Executive Officer | BMNRBITMINE IMMERSION TECHNOLOGIES, INC. Tax withholding | F | $34K 1,294 sh | Oct 26, 2026 traded Sep 30, 2026 |
| 22 | Rogers CampbellChief Medical Officer |  HTFLHeartflow, Inc.Open-market sale · 10b5-1 plan | SELL | $1.32M 23.9K sh | Oct 26, 2026 traded Oct 22, 2026 |
| 22 | Vitale Robert VDirector, EXECUTIVE CHAIRMAN |  POSTPost Holdings, Inc.Tax withholding | F | $4.09M 52.4K sh | Oct 26, 2026 traded Oct 22, 2026 |
| 22 | Westphal Mark WPRES., FOODSERVICE | POSTPost Holdings, Inc. Tax withholding | F | $1.37M 17.5K sh | Oct 26, 2026 traded Oct 22, 2026 |
| 22 | Catoggio NicolasPRES & CEO | POSTPost Holdings, Inc. Tax withholding | F | $1.45M 18.5K sh | Oct 26, 2026 traded Oct 22, 2026 |